SyntekaBio Inc

SyntekaBio, Inc. is an artificial intelligence drug development company based on genomic big data, operating primarily in South Korea. It identifies new drug candidates using DeepMatcher, an AI drug development platform that combines drug development technology with genomic big data technology. The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics-based drug side effect prediction technology. SyntekaBio was founded in 2009 and is headquartered in Daejeon, South Korea.